Position
Entropy Technologies, LP in Fulcrum Therapeutics, Inc.
Back to the book · All holders of FULC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$39.4K$11.31 → $7.67
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 12K | $135.7K | — | — | — | 0.0% |
| Q1 2026 | 10.8K | $83K | $7.67 | −$39.4K | −$13.3K | 0.0% |